Amgen Inc. (NASDAQ:AMGN) Q4 2023 Earnings Call Transcript

Amgen Inc. beats earnings expectations. Reported EPS is $4.71, expectations were $4.66.

Related Keywords

Canada ,Japan ,Florida ,United States ,North Carolina ,Puerto Rico ,Philadelphia ,Pennsylvania ,Ohio ,Brazil ,America ,American ,Robert Bradway ,Jay Bradner ,Asia Pacific ,Peter Griffith ,Salveen Richter ,Bob Bradway ,Justin Claeys ,Michael Yee ,Evan Seigerman ,Dave Reese ,Jay Olson ,Vikram Karnani ,Chris Schott ,Murdo Gordon ,Dana Farber Cancer Institute ,Novartis Institute For Biomedical Research ,Goldman Sachs ,Harvard Medical School ,Amgen ,Amgen Inc ,Nasdaq ,Call Transcript February ,Fourth Quarter ,Results Conference ,Vice President ,Horizon Therapeutics ,General Medicine ,Chief Technology Officer ,Novartis Institute ,Dana Farber Cancer ,Latin America ,Middle East ,Maritide Phase ,Nature Metabolism ,American Journal ,Prolia And ,Small Towns ,